Pancreatic Cancer Research

ResearcherUniversity of CologneActive in the last 2 years

Thomas Schmidt

Matched on ORCID iD 0000-0002-0045-1851; OpenAlex author ID A5100698425. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 3 papers · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 4 papers

Papers 9

  1. Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells. Co-author DOI 10.1016/j.ijrobp.2023.10.035↗
  2. Extent and clinical significance of the therapy-relevant tight junction protein Claudin 18.2 in pancreatic ductal adenocarcinoma - real-world evidence. Co-author DOI 10.1016/j.tranon.2024.102044↗
  3. ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells. Co-author DOI 10.1186/s13046-023-02879-8↗
  4. Altered Mechanobiology of PDAC Cells with Acquired Chemoresistance to Gemcitabine and Paclitaxel. Last author DOI 10.3390/cancers16223863↗
  5. Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC). Co-author DOI 10.3390/cancers15030628↗
  6. A mechanical memory of pancreatic cancer cells Co-author DOI 10.1101/730960↗
  7. The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.3390/cancers11020135↗
  8. Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells. Co-author DOI 10.3390/cancers11050638↗
  9. A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer. Co-author DOI 10.1016/j.drup.2017.07.001↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elisa Giovannetti · 7 shared papers, 2017–2024 · strength 1.05
  2. Erik H.J. Danen · 5 shared papers, 2017–2024 · strength 0.84
  3. Cecilia Bergonzini · 4 shared papers, 2023–2024 · strength 0.76
  4. Alessandro Gregori · 4 shared papers, 2023–2024 · strength 0.76
  5. Mjriam Capula · 4 shared papers, 2019–2024 · strength 0.70
  6. Stefano Coppola · 4 shared papers, 2017–2019 · strength 0.37
  7. Liam Andrew McDonnell · 2 shared papers, 2024 · strength 0.36
  8. Ilaria Carnevale · 3 shared papers, 2017–2019 · strength 0.28
  9. Pei Pei · 2 shared papers, 2019–2024 · strength 0.27
  10. Alexander Ioannis Damanakis · 1 shared paper, 2024 · strength 0.20
  11. Felix Popp · 1 shared paper, 2024 · strength 0.20
  12. Alexander Quaas · 1 shared paper, 2024 · strength 0.20
  13. Su Ir Lyu · 1 shared paper, 2024 · strength 0.20
  14. Karl Knipper · 1 shared paper, 2024 · strength 0.20
  15. Dirk Waldschmidt · 1 shared paper, 2024 · strength 0.20
  16. Christiane J. Bruns · 1 shared paper, 2024 · strength 0.20
  17. Adam Enver Frampton · 1 shared paper, 2024 · strength 0.18
  18. Asia Botto · 1 shared paper, 2024 · strength 0.18
  19. Ingrid Garajová · 1 shared paper, 2024 · strength 0.18
  20. Annalisa Comandatore · 1 shared paper, 2023 · strength 0.16
  21. Fatemeh Khojasteh‐Leylakoohi · 1 shared paper, 2023 · strength 0.16
  22. Luca Morelli · 1 shared paper, 2023 · strength 0.16
  23. Amir Avan · 1 shared paper, 2023 · strength 0.16
  24. Godefridus J. Peters · 2 shared papers, 2017–2019 · strength 0.16
  25. Sagar S. Manoli · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.